Koers Global Cord Blood Corporation Deutsche Boerse AG
Aandelen
6CB
KYG393421030
Gezondheidszorgvoorzieningen & -diensten
Omzet 2021 | 1,16 mld. 160 mln. 148 mln. | Omzet 2022 | 1,24 mld. 172 mln. 158 mln. | Marktkapitalisatie | 2,97 mld. 410 mln. 378 mln. |
---|---|---|---|---|---|
Nettowinst (verlies) 2021 | 508 mln. 70,15 mln. 64,68 mln. | Nettowinst (verlies) 2022 | 501 mln. 69,19 mln. 63,79 mln. | EV/omzet 2021 | -2,13 x |
Nettoliquiditeiten 2021 | 6,07 mld. 839 mln. 773 mln. | Nettoliquiditeiten 2022 | 6,66 mld. 920 mln. 848 mln. | EV/omzet 2022 | -2,97 x |
K/w-verhouding 2021 |
7,1
x | K/w-verhouding 2022 |
5,93
x | Werknemers | 1.202 |
Dividendrendement 2021 * |
-
| Dividendrendement 2022 |
-
| Vrij verhandelbaar | 38,41% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Bing Chuen Chen
DFI | Director of Finance/CFO | 48 | 01-01-09 |
Xin Xu
CTO | Chief Tech/Sci/R&D Officer | 70 | 01-11-04 |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Jennifer J. Weng
BRD | Director/Board Member | 56 | 01-01-09 |
Ting Zheng
CEO | Chief Executive Officer | 52 | 01-01-09 |
Director/Board Member | 56 | 01-01-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+25,52% | 88,99 mld. | |
-24,52% | 74,82 mld. | |
-5,56% | 25,03 mld. | |
+4,31% | 17,88 mld. | |
-14,25% | 16,43 mld. | |
+2,97% | 15,77 mld. | |
+79,20% | 13,21 mld. | |
+70,11% | 13,09 mld. | |
+40,44% | 12,9 mld. |